Glizamide 80 Tablet contains Gliclazide 80mg, a sulfonylurea class oral antidiabetic agent used for the effective management of type 2 diabetes. It works by stimulating insulin secretion from pancreatic beta cells to control both fasting and postprandial blood glucose levels.
This tablet falls under the diabetes care segment, providing a reliable oral therapy in conjunction with diet and lifestyle modifications. The 80mg dosage is designed for patients requiring higher or maintenance doses to achieve optimal glycemic control.
Glizamide 80 Tablet is widely prescribed by endocrinologists, general physicians, hospitals, and clinics, making it a high-demand product for PCD pharma franchise and B2B distribution. Its efficacy and safe dosing encourage patient adherence and repeat prescriptions.
For PCD pharma franchise and B2B partners, Glizamide 80 Tablet represents a profitable and high-demand opportunity. With steady demand from hospitals, clinics, and retail pharmacies, it is suitable for domestic distribution, export, and third-party manufacturing, ensuring sustainable business growth and attractive margins.